Cancer intestine

Administrative region Lung cancer Breast cancer Skin cancer Intestinal cancer Lim- phomas... 

In addition to the treatment of pain and inflammation, COX-2 inhibitors might be of benefit in other indications. Expression of COX-2 in colon cancer, intestinal adenomas, and other cancer cells as well as clinical studies with COX-2 inhibitors, suggest the use of COX-2 inhibitors in cancer (Masferrer et al., 1999). Expression of COX-2 in angiogenesis follows the same route since angiogenesis is important for blood supply and hence the growth of many tumors. 

In a study by Kearney et al. (1995) of the Department of Nutrition, Harvard School of Public Health, low folic acid levels were found to correlate with an increase in cancerous intestinal polyps, as well as with cancer in general. 

I ARC on Cancer Intestinal Microecology Group, 1977, Dietary fiber, transit-time, fecal bacteria, steroids, and colon cancer in two Scandinavian populations. Lancet 11 207. 

Folate antagonists (eg, methotrexate and certain antiepileptics) are used ia treatment for various diseases, but their adininistration can lead to a functional folate deficiency. Folate utilization can be impaired by a depletion of ziac (see Zinc compounds). In humans, the intestinal bmsh border folate conjugase is a ziac metaHoenzyme (72). One study iadicates that the substantial consumption of alcohol, when combiaed with an iaadequate iatake of folate and methionine, may iacrease the risk of colon cancer (73). Based on this study, it is recommended to avoid excess alcohol consumption and iacrease folate iatake to lower the risk of colon cancer. 

Growth inhibition by TGF- 3, associated with inhibition of c-myc, cdks, reduction in cyclin D1 levels, and inhibition of cdk-4-associated Rb kinase activity, as well as induction of cdk inhibitors pi5 and p27, has been noted in intestinal epithelial cells. Loss of responsiveness to growth inhibition from TGF- 3 occurs in many cell types including breast, colorectal carcinoma, and pancreatic carcinoma cells. Mutational inactivation of T 3RH represents one mechanism of this process, which in many cases, leads to the development of gastrointestinal cancer. Thirteen percent of colorectal carcinomas are thought to be associated with a replication error (RER) or microsatellite instability phenotype. Subsequent inactivation of T 3RII and... 

TRPV5 and TRPV6, also known as the epithelial Ca2+ channel or ECaC (TRPV5) and Ca2+transporter 1 or Ca2+ transporter-like (TRPV6), are the only two Ca2+-selective TRP channels identified so far. They may function in vitamin D-dependent transcellular transport of Ca2+in kidney, intestine and placenta. TRPV6 is also expressed in pancreatic acinar cells, and in prostate cancer, but not in healthy prostate or in benign prostate hyperplasia. 

Both influx and efflux transporters are located in intestinal epithelial cells and can either increase or decrease oral absorption. Influx transporters such as human peptide transporter 1 (hPEPTl), apical sodium bile acid transporter (ASBT), and nucleoside transporters actively transport drugs that mimic their native substrates across the epithelial cell, whereas efflux transporters such as P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP), and breast cancer resistance protein (BCRP) actively pump absorbed drugs back into the intestinal lumen. 

Don Francisco went back to Granada to spend his final years. There, he still kept an interest in a fraction of his father s land which he had inherited. In 1981, his health visibly declined, and cancer of the intestines was diagnosed. He had to sutler two major operations which were of no avail, and finally he accepted his fate with great fortitude and dignity. Don Francisco spent the following trying months surrounded by his closest relatives, receiving the most devoted care from his wife. He died on November 19, 1983. 

Rice bran fiber has fructo-oligosaccharides - a pre-biotic that helps friendly bacteria to proliferate in the gastrointestinal environment and improves intestinal and colon health (Tomlin and Read, 1988). Recent studies in humans (Kahlon and Chow, 1997) have revealed that rice bran fiber not only normalizes bowel function, but also helps in conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) and Crohn s disease, and lowers the lipid levels. Rice bran fiber has been shown to significantly reduce renal stones (Jahnen et al., 1992). It is a good source of fiber in weight loss programs and therapeutic fiber diets for diabetics and heart patients. Fiber diets prevent cancer of the colon and large bowel, control obesity and improve bowel function. 

Anti-cancer effect (Nesaretnam et. al., 1998) Human mammary and large intestinal cancer inhibition (Nesaretnam et al., 1998). 

Myo-inositol is one of the most biologically active forms of inositol. It exists in several isomeric forms, the most common being the constituent of phospholipids in biological cell membranes. It also occurs as free inositol and as inositol hexaphosphate (IP6) also known as phytate which is a major source from food. Rice bran is one of the richest sources of IP6 as well as free inositol. Inositol is considered to belong to the B-complex vitamins. It is released in the gastrointestinal tract of humans and animals by the dephosphorylation of IP6 (phytate) by the intestinal enzyme phytase. Phytase also releases intermediate products as inositol triphosphate and inositol pentaphosphate. Inositol triphosphate in cellular membrane functions as an important intra- and intercellular messenger, that merits its value as a nutritional therapy for cancer. 

Alterations in other gastric secretions, such as pepsinogens and blood group substances also take place in chronic atrophic gastritis. The secretion of pepsinogen I has been used as an indicator of intestinal metaplasia and gastric cancer (21, 22). 

Sugie, S. et al., Inhibitory effects of plumbagin and jugloneon azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett., Ill, 111, 1998. 

Ireson, C. R. et al., Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine, Cancer Epidemiol. Biomarkers Prev., 11, 105, 2002. 

Shamsuddin, A.M., Elsayed, A.M. and Ullah, A. (1988). Suppression of large intestinal cancer in F344 rats by inositol hex-aphosphate. Carcinogenesis 9, 577-580. 

Siegers, C.P., Bumann, D., Trepkau, H.D., Schadwinkel, B. and Bareytton, G. (1992). Influence of dietary iron overload on cell proliferation and intestinal tumorigenesis in mice. Cancer Lett. 65, 245-249. 

Prolonged hypergastrinemia leading to the development of colonic polyps and potentially adenocarcinoma in rats was a concern that has proven to be unfounded with long-term use in humans.19 The FDA has stated that there is insufficient evidence linking PPI use to atrophic gastritis, intestinal metaplasia, or gastric cancer.20... 

Surgical intervention is a potential treatment option in patients with complications such as fistulae or abscesses, or in patients with medically refractory disease. Ulcerative colitis is curable with performance of a total colectomy. Patients with UC may opt to have a colectomy to reduce the chance of developing colorectal cancer. Patients with CD may have affected areas of intestine resected. Unfortunately, CD may recur following surgical resection. Repeated surgeries may lead to significant malabsorption of nutrients and drugs consistent with development of short-bowel syndrome. 

The risk of colon cancer appears to be inversely related to calcium and folate intake. Calciums protective effect may be related to a reduction in mucosal cell proliferation rates or through its binding to bile salts in the intestine, whereas dietary folate helps in maintaining normal bowel mucosa. Additional micronutrient deficiencies have been demonstrated through several studies to increase colorectal cancer risk and include selenium, vitamin C, vitamin D, vitamin E, and 3-carotene however, the benefit of dietary supplementation does not appear to be substantial.11... 

Comorbid conditions, such as chronic ulcerative colitis, particularly when it involves the entire large intestine, and to lesser extent Crohn s disease, also increase the risk of colon cancer. Overall, persons diagnosed with either disease constitute about 1% to 2% of all new cases of colorectal cancer each year. 

Familial adenomatous polyposis An inherited condition in which numerous polyps form, mainly in the epithelium of the large intestine. While these polyps start out benign, malignant transformation into colon cancer occurs 100% of the time when not treated. 

---